Social support and memory in postmenopausal women: a careful null
A secondary analysis of the ELITE hormone-therapy trial found hints that social ties tracked with cognition, but none survived correction for multiple testing.
For how we live.
Evidence-grading explainers on the week's viral study.
A secondary analysis of the ELITE hormone-therapy trial found hints that social ties tracked with cognition, but none survived correction for multiple testing.
Linking exome data to electronic medical records solved 15% of unexplained hearing-loss cases and flagged new candidate genes — while showing what the records could not supply.
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
In 415,000 New Jersey births, infants of mothers who screened positive for depression died before age one at more than three times the rate, an association steady across race, income and preterm birth.
Screening 2,904 proteins in early pregnancy, researchers found low maternal isthmin-2 was the strongest signal for later preeclampsia or fetal growth restriction, validated in two cohorts.
Across 16,893 high school athletes screened over 15 years, 0.36% had T-wave inversions. Four were later found to have hypertrophic cardiomyopathy, a leading cause of sudden cardiac death in the young.
A small double-blind trial found a single 5.5 mg/kg dose lifted sprint power for hours, alongside higher noradrenaline and lower perceived effort — but it was 12 people, mostly men.
A Swedish study of 10,693 ACL reconstructions in registered football players found no link between graft type and revision surgery. Age and playing level mattered far more.
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
In 5,520 children across 34 states, prenatal exposure to regulated public-water fluoride showed no association with emotional or behavioural problems overall — with one caveat in a secondary model.
In the 172-patient PARADIGM trial, azacitidine plus venetoclax more than doubled median event-free survival versus induction chemotherapy — but it was a phase 2 study not powered for overall survival.
In an early-phase trial of 136 previously treated patients, daraxonrasib produced responses in 31–37% depending on dose — but 54% had a serious side effect, and this is a phase 1–2 study.
In the Ket-BD trial, four IV ketamine infusions over two weeks lowered depression scores more than an active placebo, with no manic switches observed in 63 analysed patients.
A transcriptomic sub-study of the CALERIE calorie-restriction trial links 151 genes to preserved leg strength during weight loss, independent of how much body mass was lost.
Applied to 411,000 UK Biobank adults, the Edmonton staging system and the Lancet Commission's clinical-obesity model classified severe disease alike but diverged on who counts as early-stage.
In 2.5 million Swedish births followed to adulthood, mothers' early-pregnancy obesity was linked to a stepwise rise in offspring cardiovascular disease, though sibling analyses temper the size.
In the NSABP B-59 trial, adding the immunotherapy to neoadjuvant chemotherapy did not significantly improve event-free survival, while immune-related side effects more than doubled.
In 53 patients, oral fluconazole — but not a mouth-only antifungal — cut gut Candida and coincided with improved disease activity. The study was observational, brief and unblinded.
Among 3,032 couples sampled before conception, higher maternal and paternal vitamin B12 both tracked with lower predicted birth-defect prevalence. The paternal pattern was weaker, and this is observational.
Cochrane reviews rate anti-inflammatory painkillers a very effective treatment for menstrual cramps, roughly doubling the odds of good pain relief. Exercise helps too, but on lower-quality evidence.
A self-reported cross-sectional study of 599 residents found sharp deterioration across every measured dimension of oral health during the war — a neglected corner of the humanitarian-health picture.
Trials put the pregnancy rate after emergency contraceptive pills at roughly 1-3%. But the risk rose more than threefold in obese women, and the levonorgestrel pill fared worst of all.
In 7,530 people from two long-running cohorts, central sleep apnea with high oxygen overshoot carried elevated cardiovascular risk. The same apnea with low overshoot did not.
The REACT study imaged people aged 18 to 70 with no known cardiovascular disease. Atherosclerosis was already present in some people in their twenties, and it was usually in the legs, not the heart.
PRESC1SE-MI covered 67,624 chest-pain presentations at 19 hospitals. The one-hour troponin pathway matched the three-hour one on safety, and median length of stay was identical: 309 minutes.
A Chinese cohort found serum PCBs associated with a higher calculated 10-year cardiovascular risk. The longitudinal results did not survive correction for multiple testing, and no events were counted.
In a 40-person crossover trial, 10 mg and 20 mg of edible THC degraded lane-keeping while whole-blood THC peaked at 1.6 and 3.4 ng/mL — near or under the thresholds police enforce.
SWITCH-SWEDEHEART randomised regions rather than patients. Over 17,095 people, a default prasugrel policy did not lower ischaemic events against ticagrelor, but major bleeding was lower.
DANISH-CRT randomised 1,000 patients to electrically targeted or conventional left ventricular lead placement. After nearly four years, death and heart failure admissions were the same.
PRAGUE-26 randomised 558 patients across 11 Czech hospitals. The seven-day composite fell from 6.8% to 0.7%, driven by cardiorespiratory collapse, with no clear bleeding penalty.
PREMIUM tested prasugrel alone against aspirin plus prasugrel in 2,216 STEMI patients in Japan. Monotherapy failed to show noninferiority, and the confidence interval sat above one.
The INTERSECT study asked 11,302 women 6 to 12 weeks postpartum about birth trauma. The spread between countries is far wider than the average, and that is the finding.
POET II randomised 508 stabilised patients to stop antibiotics or complete the standard course. The safety endpoint met noninferiority; relapse of infection did not go the same way.
The first double-blind sham-controlled trial of pulmonary vein isolation found quality of life improved in both arms. Most of the benefit patients feel appears not to come from the ablation.
Cochrane found a clinically important 15.2-point pain reduction across 249 trials. A reanalysis excluding trials with fewer than 70 participants put the effect below the threshold that counts as meaningful.
ABYSS and SMART-DECISION together cover 6,238 stable patients. Discontinuation cleared both noninferiority margins, though the authors say the primary endpoint's composition limits what it shows.
In 1,238 people from two community cohorts, apnea severity showed no link to depressive symptoms. Sleep fragmentation did, and that association disappeared once insomnia symptoms entered the model.
LIBREXIA-ACS enrolled 14,194 patients before stopping for futility. Milvexian did not reduce events, but intracranial and fatal bleeding were identical to placebo, which is the class's whole premise.
CARDIO-TTRansform randomised 1,432 patients with transthyretin amyloid cardiomyopathy to eplontersen or placebo for 140 weeks. The confidence interval around the primary result crosses one.
A facility-based study of 5,053 infants finds undernutrition begins earlier than the age group nutrition programmes usually screen — and that weight-for-age caught far more of it than arm-circumference tape.
Guidelines have hedged on anticoagulation for people with one stroke risk factor. SINGLE-AF randomised 1,803 patients in South Korea, and the events it counted were very few in both arms.
A meta-analysis of 90,000 people found these diabetes-origin drugs reduced kidney disease progression by 37% and cardiovascular events by 23%, and the benefit was similar in people who did not have diabetes.
A 740,744-child natural experiment tested a decade-old hypothesis that rotavirus vaccine might prevent type 1 diabetes. It found no protective effect — and no evidence of harm either.
WHO and ILO estimate about 17% of workers face hazardous noise. Their review of whether it causes heart disease found only low-certainty signals — one for heart-attack incidence, little for stroke or blood pressure.
ACACIA-HCM met both primary endpoints in symptomatic non-obstructive HCM. The gains were real but small, and one in ten patients had a reversible drop in pumping function.
A 293-woman Dutch trial found more women reported improvement at 12 months with perioperative oestriol cream than placebo. Anatomical success, surgical success and reintervention were unchanged.
A 32-study review attaches a five- to eight-fold per-tackle concussion risk to one body position, and finds youth players use it more often. A New Zealand school study maps where the force lands.
Two birth cohorts totalling 9,801 children were sorted into eight developmental patterns. The classic progression was one of them, and one of the smallest.
High urate levels track with worsening kidney disease, so treating them seemed a logical way to slow it. Two trials that lowered urate with allopurinol found the kidneys declined at the same rate anyway.
Among 603 RECOVER participants, 118 were classified as likely having Long COVID. The primary analysis found no association with preterm delivery, and one secondary signal that only appeared in a sensitivity analysis.
The same audit found high-performance female athletes well represented in the field — and that the studies generating prevalence figures lean on self-reported food records and MET lookup tables.
SleepCARE randomised 219 Australian women receiving chemotherapy for breast cancer to CBT-I, bright light therapy, both, or sleep hygiene. Only CBT-I moved insomnia — and nothing moved fatigue.
A meta-analysis of 27 studies found a dose-response pattern that runs against the nightcap logic: the sedative effect needs a high dose, and the REM disruption starts at a low one.
Suppressor tRNAs have been a promising idea for nonsense mutations for years, held back by weak activity and delivery. A Science paper reports one chemical tweak and one redesigned nanoparticle.
Leisure exercise reliably protects the heart. Physical activity done for a living shows mixed or even adverse associations — and some meta-analyses find higher mortality in men with the most physically demanding jobs.
The range is the finding, not a failure of the study. 1,712 former players died between 2008 and 2021; 338 brains were examined, and who donates a brain is not random.
The longest human trial of low-dose rapamycin for healthy ageing found no change in visceral fat, its own primary outcome. The positive findings it is quoted for rest on eight women.
In two phase 3 trials, 38.8% and 35.9% on baricitinib 4 mg reached near-complete scalp regrowth at 36 weeks against 6.2% and 3.3% on placebo — the first drug class to do this for the condition.
The ODDESSI trial ran in 30 clusters across five NHS trusts in England. Time to relapse was unchanged; inpatient admission, re-referral and service-user ratings all moved in Open Dialogue's favour.
A 1.5-million-person records study reports lower mortality with GLP-1 drugs than with SGLT2 inhibitors, and the largest absolute gains in people with serious mental illness. The design cannot prove it.
Comparing US adults vaccinated just before and just after the changeover from the live to the recombinant shingles vaccine, researchers found a 9% lower cardiovascular burden over seven years.
A cohort with serial MRI and autopsy data found earlier menopause tracked faster cognitive decline and white matter damage. The per-year coefficients are very small.
A 4,066-person survey series across Funafuti and the outer islands links second-hand smoke exposure — reported by 61% of participants — to obesity and elevated STOP-Bang scores.
A mandatory citywide programme sequenced 782 genes in 1,000 prospective couples. The at-risk rate was double that of a comparable Australian study, and most flagged couples still chose to marry.
In 276 adults tested at 60, the differences in GrimAge and DunedinPACE were small, their intervals crossed zero, and most of what was there disappeared once smoking was accounted for.
The MTA trial randomised 579 children and found medication management clearly superior short-term. Its own long-term follow-up found the treatment groups no longer differed by 6 to 8 years.
A Cochrane review found women doing pelvic floor muscle training were eight times more likely to report their stress incontinence cured than untreated women — with the strongest evidence for that one condition.
A meta-analysis of 116 randomised trials found weight, waist and body fat falling steadily up to 300 minutes a week. In one 24-week trial, 48% of participants compensated by about 308 kcal a day.
Among 17,508 notified cases from 2007 to 2021, 1.49% died of Chagas and 5.83% of other causes — with digestive complications, not cardiac ones, carrying the highest cumulative risk.
A study of 9,248 US women published in May 2026 found perimenopausal women twice as likely to fall into the lowest cardiovascular health band. The design cannot show that the decline happens within individuals.
Overall musculoskeletal injury was lower during pregnancy and the year after than in non-pregnant periods. Spine and back injuries were the exception, rising through pregnancy and postpartum.
A 614-donor autopsy study tied advanced CTE to dementia independently of other brain disease. A separate imaging report in three former athletes hints at a test for the living. The caveats on both are heavy.
Stanford's SleepFM, published in Nature Medicine in January 2026, is the most consequential sleep paper of the year. Its own limitations section explains why it is not yet a clinical test.
A 100-child randomized trial in Uganda found a cheap supplement lowered infection rates on top of standard hydroxyurea therapy — though the authors say it needs a bigger trial before it changes practice.
In 62 adults scanned under psilocybin during rest, meditation, music, and film, brain networks reorganized differently by setting — and more reorganization tracked with more positive experiences.
Using causal-inference methods on 1,269 people, researchers linked two bacterial genera to depression independent of body weight and medication — the first such evidence in humans, not proof of mechanism.
An analysis of a decade of surveillance data shows the system leans heavily on hospitals and misses cases in the community — the weakness that lets measles circulate undetected between outbreaks.
Mice lacking the chaperone GRPEL2 stayed leaner on a high-fat diet and kept better insulin sensitivity — an early mechanistic finding, not a treatment, and so far only in mice.
A Cochrane review of 50 trials found cranberry products lower UTI risk in women with recurrent infections and in children, but no benefit in the elderly, in pregnancy, or in bladder-emptying problems.
Chronic granulomatous disease is usually X-linked in Western cohorts. A multicentre Middle East and North Africa registry found the opposite pattern, alongside late diagnosis and a median survival of 8.5 years.
A national analysis of 2,985 haemorrhage deaths from 2015 to 2024 found no significant change over time — and Indigenous women dying at 2.87 times the rate of White women.
Observational studies had linked proton pump inhibitors to fractures, dementia, kidney disease and more. A randomised trial collected all of those outcomes and found only enteric infections.
Twenty months of under-mattress sensor data from 95,819 people found that chronic irregularity was common, persistent, and tracked with 46% higher odds of hypertension.
VPM1002 did not show non-inferiority to BCG for preventing tuberculosis infection in a phase 3 trial across sub-Saharan Africa. Far fewer infections occurred than planned, leaving the comparison unresolved.
A randomised trial tracked infants' cortisol and attachment; a five-year follow-up tracked mental health. Graduated extinction improved sleep with no sign of long-term damage — or lasting benefit.
The TAME trial randomised 276 adults with diagnosed anxiety disorders to mindfulness-based stress reduction or escitalopram. The difference on the primary measure was 0.07 points, inside the noninferiority margin.
A 2025 review walked through every study of low-dose rapamycin in healthy adults. The immune findings are real, the outcome data do not exist, and the review's own worked example does not add up.
A decade of eardrum repair delivered on Country across nine Queensland communities produced closure rates below metropolitan benchmarks — and a follow-up rate most urban surgical services do not achieve.
A Nurses' Health Study II analysis estimated 37% of incident reflux symptoms were attributable to five modifiable factors. Body weight was the largest single one, at 19%.
The IARC calls night shift work probably carcinogenic. A 2026 meta-analysis of nurses shows why 'probably' is careful: the breast cancer signal appears only after decades, and shrinks to nothing once bias is corrected.
In-lab trials that restricted sleep on weekdays and allowed recovery at the weekend found insulin sensitivity and glucose tolerance still worsened. Population surveys point the other way, and the designs explain why.
Observational studies link higher water intake to healthier kidneys. When a randomised trial coached people with kidney disease to drink more, their filtration fell at the same rate as the control group.
A phase 2 trial of dasatinib plus quercetin missed its bone endpoint. A senolytic injected into the eye produced a 5.6-letter vision gain whose confidence interval crosses zero.
Two cohorts published ten days apart. One found the PFAS mixture more than doubling the odds of hypertension at 24 to 28 weeks; the other found lower birth weight, but only in female infants.
Two national studies settle the question the trials could not: in England, cancer rates fell 87% among those vaccinated at 12-13; in Sweden, the risk was cut by nearly two-thirds.
A 2,836-pair analysis of the ECHO cohort found one of four compounds associated with parent-reported sleep problems. A Shanghai study of bone density found opposite directions in girls and boys.
ACHIEVE randomised 977 older adults and measured three-year cognitive change. The difference between hearing aids and health education was 0.002 SD units, p=0.96. One subgroup result is doing a lot of work.
Most women have a recurrence within a year of standard treatment. A 2025 trial stopped early once treating a woman alone proved inferior to treating her and her male partner together.
The Pittsburgh Sleep Quality Index global score is the field's default outcome. Tested in a large South African cohort, its single-factor structure fit poorly and internal consistency was modest.
A network meta-analysis of 24 randomised trials ranks oral dutasteride first on 24-week hair density. The adverse-effect literature behind these drugs is separately, and seriously, contested.
Cochrane reviews find honey modestly eases a child's cough and does about as well as dextromethorphan, while OTC cough medicines have not beaten placebo in children. The honey trials excluded infants under one.
Two double-blind crossover studies in people who had put themselves on gluten-free diets failed to reproduce a gluten effect. One found a different wheat carbohydrate did it instead.
In two large clinics, the live birth rate per woman who returned to use her eggs was around 39-50% under 35 or 38, but far lower for older women — and most women who froze never came back to use them.
A meta-regression of 23 hypertrophy studies found total intake the strongest predictor and no timing effect after adjustment. A later network meta-analysis of 116 trials still favours post-exercise, narrowly.
A laboratory trial found a light-emitting e-reader really does suppress melatonin and delay the body clock. Two 2026 field studies found the day-to-day effect runs almost entirely through when people go to bed.
In 2023 declining taurine was proposed as a driver of ageing. Two years later the same journal published human, monkey and mouse data in which taurine rose or stayed flat.
Feeding studies find that when fructose replaces other carbohydrate at equal calories, liver fat barely moves. The liver damage tracks the extra energy, not the sugar's molecular identity.
A Brazilian laboratory study found both a prototype strain and an emergent reassortant killed neural progenitors and collapsed cortical structure. This is a dish, not a pregnancy.
A network meta-analysis of 331 trials and 34,285 adults found no significant differences between the main psychotherapies, with one exception. In children and adolescents the picture is narrower.
The trials that made eye vitamins a standard recommendation enrolled only people who already had substantial disease. In AREDS2, neither omega-3 nor lutein beat placebo on the primary endpoint.
Weekly fluconazole kept most women free of thrush during treatment, yet by 12 months, six months after stopping, the advantage had narrowed sharply. A newer drug shows more durable suppression.
In modern couples timing intercourse, an estimated 18% of women aged 35-39 failed to conceive within a year — not one in three. The most alarming figures come from models, not from watching real couples try.
In 555,904 matched adults, screening endoscopy cut gastric cancer mortality in the 50s and 60s. Past 80, or with heavy comorbidity, the association reversed.
A 1,224-person biomonitoring study found four compounds only in firefighter serum. A separate 65-person pilot in Texas asked whether that matters for cognition, and got a partial answer.
In the 240-woman ALTAR trial, methenamine hippurate was non-inferior to standard low-dose antibiotic prophylaxis over a year. Most other non-antibiotic prevention strategies still rest on weak evidence.
In a 22,785-user study of one temperature-based app, typical use failed 6.9 per 100 woman-years and perfect use 1.0 — but the study came from the maker, and traditional methods vary widely.
A consortium reduced overnight sleep studies to nine composites. Two tracked with better cognition. None tracked with whether a person later developed dementia.
A large randomised promotion trial and sibling studies find some real benefits in infancy — fewer gut infections, less eczema — but the sweeping long-term advantages shrink once confounding is accounted for.
An umbrella review of 29 systematic reviews and 863 randomised trials found most treatments resting on critically low-quality evidence. Animal work suggests soreness can arise without muscle damage at all.
The best long-term trial found trained skills can last a decade. Whether they transfer to daily life, or hold off dementia, is where the evidence — and the FTC — parted ways with the marketing.
Both things are true, and both rest on high-certainty evidence. The phase 3 trial and the meta-analysis that followed it measured different outcomes and reached opposite-sounding conclusions.
A million-woman Danish cohort found a modest rise in antidepressant use among hormonal contraceptive users. A Cochrane review of weight found no evidence the pill causes weight gain.
Two datasets report an age-independent fall in men's testosterone across birth cohorts. A separate study of nine thousand men found much of the variation between cohorts came from the tests themselves.
A UK Biobank analysis broke ultra-processed food into 37 specific ingredients rather than treating it as one block. Flavours, colourings, sweeteners and sugars carried the signal; processing aids and added fibre did not.
Cochrane's living review of 104 trials rates high-dose atropine and orthokeratology moderate certainty. The low-dose atropine most widely used sits at very low certainty, and two Western trials disagree.
A network meta-analysis found six treatments clearing the clinically important threshold in the short term. It also graded 98.6% of the evidence very low certainty, and found nothing that held up past a year.
In a meta-analysis of 25 randomised trials and 26,610 participants, stretching produced no reduction in sports injuries. Strength training cut them to under a third — on a much smaller evidence base.
Two Cochrane reviews found low- to very low-certainty evidence that floss slightly reduces gum inflammation. Neither found a single trial measuring interproximal decay, the thing flossing is sold to prevent.
The LEAP trial cut peanut allergy in high-risk infants from 13.7% to 1.9%. A second trial found the benefit real but harder to achieve — and only in children who actually ate the food.
A 223-study meta-regression reports sperm concentration falling 51.6% since 1973. Two published critiques argue the method cannot support that reading. Both sides are peer-reviewed.
Longitudinal data and a meta-analysis of 159,425 children find consistent associations between screen time and development — but the effects are small, observational, and thinner than the guidelines imply.
After four weeks, the comorbid-insomnia group's blood pressure fell 20 points more than the apnea-only group. The finding flips the usual framing of COMISA as simply a worse-outcomes phenotype.
Pooling under 11,000 pregnancies, a meta-analysis found no statistically significant association either way, with the three underlying studies disagreeing on which direction the risk even points.
A tightly controlled crossover trial separated low energy availability from low carbohydrate availability for four days. One hormone moved clearly; most did not, and performance did not move at all.
A registry study spanning 4.9 million people separates where the most deaths occur from where the inequality is largest. Heart disease and lung disease give different answers.
Both morning and evening chronotypes showed elevated risk against the middle ground, and the effect nearly doubled in people who also had sleep apnea.
Four separate trial emulations, each with a different comparator, all pointed the same direction. The strongest effect appeared among people being treated for alcohol use disorder.
Blood samples from a West African vaccine trial show both licensed Ebola vaccines generate antibodies that bind Bundibugyo virus — the species with no vaccine of its own, now causing DRC's largest outbreak on record.
A survey of 322 college students found a dose-response pattern: the more intensely someone specialized in a single sport young, the greater their odds of chronic injury, nearly fivefold.
Peruvian Andeans are famous for high haemoglobin at altitude. A genome-wide scan finds the alleles under recent positive selection are the ones that lower it — a pattern closer to Tibetans than expected.
A meta-analysis of six studies found a moderate effect on sleep duration and a small one on depressive symptoms — with high heterogeneity on both.
A Finnish registry of over 123,000 women found pre-eclampsia linked to an 11% lower breast cancer risk decades later. Hormone therapy raised risk by a similar amount in both groups.
Tracking 3.6 million women over 24 years, researchers found women with endometriosis were nearly 3.5 times more likely to develop the condition before 40. Seventy percent of cases still have no identified cause.
A twelve-athlete study tested morning, late-afternoon and late-evening sessions across the fasting month — and found the deficit was specific to time of day, not spread evenly across it.
Gene-edited islet cells implanted in a person's forearm are still functioning more than a year later. It is a single case report, and will need many more patients to mean anything.
Years of observational data suggested 4CMenB cut gonorrhea risk by a third or more. A placebo-controlled trial in 654 people at high risk found essentially no effect at all.
Tirzepatide and semaglutide showed comparable psychiatric risk profiles against each other over two years. Against earlier GLP-1 drugs, semaglutide came out ahead on all three measures.
A registry snapshot of 13,455 adults measures how far the biologic era has moved severe asthma toward remission, and finds the inflammation these drugs target still detectable in most patients.
The KADS extension followed 130 patients who had already been through a ketamine trial. Response fell from 30% at treatment's end to 17% a month later.
A 398-caregiver study across all five island groups finds the single biggest predictor of HPV vaccination was knowing the vaccine was free — after a decade of the programme running.
Stress peaked during the fasting month and fell afterwards, but depression and anxiety stayed flat. The consistent finding across every phase was that sleep quality tracked mental health.
A registered report fit identical models to 11 longitudinal studies covering 175,070 people. The subjective feeling carried the signal; the objective count of social contacts largely did not.
The UK and Rwanda reported the highest anxiety, depression, and vasomotor symptom scores; Nepal, Sri Lanka, Malaysia, and Singapore reported the lowest. Burnout emerged as the symptom most connected to everything else.
Gastric bypass patients lost roughly 28% of body weight at three years, against 7-11% for tirzepatide or semaglutide — even among patients who stayed on the drugs continuously for at least a year.
In 377 patients, hypoxic burden — a metric combining how often, how deep, and how long oxygen drops — tracked with abnormal nighttime blood pressure patterns where conventional measures didn't.
A quasi-experimental analysis of 23 hospitals finds about 95 additional self-harm and suicide-related emergency visits a month after the law changed, alongside fewer psychiatric admissions.
A burden-of-disease calculation built on EU noise-mapping data puts numbers on two outcomes that noise research has mostly ignored. The confidence intervals are as informative as the estimates.
A Danish registry study of 136,842 women found elevated antidepressant and anxiolytic prescribing in the decade preceding diagnosis, with psychiatric hospital contacts rising about five years before.
Three cohorts, 147,374 people, 30 years and 35,798 deaths. The dose-response curve flattened above 120 minutes per week, and the cancer signal appeared at the low end, not the high end.
A stepped-wedge trial across 165 women's and girls' Australian football teams shows how far implementation support moves uptake — and how much larger a trial would need to be to prove it prevents injuries.
In 273,466 people with substance-related hospital admissions, psychosis was far more common after hallucinogen admissions, until adjustment for preexisting conditions erased the link.
University of Florida researchers identify excess glycan production as a driver of Alzheimer's pathology, and find oral glucosamine worsened cognition in mice and tracked with faster decline.
Data from 20 European countries covering 2014 to 2024 tracks lung function, nutrition and infection through the arrival of triple modulator therapy — and the new complications arriving with age.
Extremely dense breasts on a routine screening mammogram were linked to a 20% lower likelihood of menopause over the following years, a possible marker of reproductive aging.
Games missed to rest or load management rose 125% over nine NBA seasons while serious injuries rose 43% — and players who sat out for rest showed no significant reduction in subsequent injury risk.
The association held across most demographic subgroups, but not among Black patients, a gap the study doesn't explain. Two-year follow-up limits what it can say about longer-term risk.
Nearly twice as many CPAP-treated patients saw their HFpEF-like markers improve at one year compared with those who went untreated — in a population sleep specialists have historically deprioritized for treatment.
After 12 months, HbA1c was 6.5% among people managed by community health workers versus 7.1% among those referred to clinics. With 103 participants analysed, the confidence interval crosses zero.
Thirty-five people received VERVE-102 in a phase 1 trial. The edit is permanent, the follow-up is short, and the endpoint measured was cholesterol, not heart attacks.
Switzerland allows limited psilocybin use for treatment-resistant depression. A review of 19 patients found meaningful improvement, but remission in barely a fifth to a quarter.
35% of patients on tezepelumab stopped oral steroids entirely, versus 21% on placebo, without losing asthma control — in a drug that targets inflammation upstream of the eosinophil count doctors usually check.
Orexin antagonists were long avoided in sleep apnea over fears they'd suppress the arousals that end dangerous breathing pauses. Sixteen patients on daridorexant showed no meaningful change in breathing severity.
A single-author analysis of Global Burden of Disease estimates finds the region's neurodevelopmental picture split in two — and argues the flat autism curve reflects diagnostic capacity, not risk.
An 8-year-old boy had brain inflammation with no respiratory symptoms. Every respiratory, blood and rectal sample tested negative; the virus was in his cerebrospinal fluid alone.
In 38,283 nurses tracked through the transition, low-insulinemic and planetary-health eating patterns had the strongest associations with less weight gain. The average woman still gained 0.8 kg a year.
EPISODE randomized 144 people with treatment-resistant depression across four arms. High-dose psilocybin missed its main outcome, even as secondary measures showed symptom benefit.
Women who reported vigorous physical activity had a lower arousal index, less time awake after falling asleep, and more total sleep time. The same association didn't hold for arousal index in men.
A linked-registry cohort of New South Wales residents from 2001 to 2018 finds cancer risk in people with intellectual disability inverts with age — higher when young, lower after 50.
A 150-woman real-world comparison found combination therapy cut symptom scores further and produced more clinical responders. Endometrial thickness rose slightly but stayed normal.
A Qatar Biobank analysis derived local cut-points and found WHO's standard numbers misclassified more than half of men and nearly half of women in the sample.
The comparison group matters: against veterans with unspecified narcolepsy diagnoses, the mortality gap widened to 140% higher odds. The study can't yet say what's driving the excess deaths.
Using genetic variants as instruments, researchers found exercise and wellbeing lowered risk of PCOS, endometriosis and menstrual disorders, while screen time and mood swings raised it.
Twenty-four healthy volunteers received all three drugs in a crossover trial. At 30 mg, 2C-B matched MDMA's intensity and produced psilocybin-like states, without psilocybin's anxiety.
Buntanetap showed dose-dependent cognitive benefit in biomarker-positive patients with mild disease. The company's announcement does not say what happened in the full 351-patient population.
The PERTH trial is a 60-person pilot, and its outcome was urinary chemistry rather than health. Within those limits it answered a question people keep asking.
In women 41 to 50, late perimenopause and postmenopause brought measurable declines in lung volume, with postmenopausal women losing up to 310 mL of FEV1. HIV status didn't change the pattern.
The first federal survey to ask about psilocybin specifically finds 2.8% past-year use, concentrated among young, white, college-educated men. People with recent depression had 37% higher odds.
Among 1.2 million participants in Paris endurance races over ten years, 17 suffered sudden cardiac arrest. Nearly all of them lived, and researchers still can't explain almost half the cases.
The LiverScreen project ran transient elastography across nine countries, then sent everyone who screened positive to a hepatologist. The gap between the two numbers is the interesting part.
Of 1,363 evaluable patients matched to drugs by tumor genetics, 7% became exceptional responders. Activity across all 37 drugs was modest, and severe side effects hit over a quarter.
A 20-point rise in apnea severity tracked with about three times more blood pressure increase in adults with a BMI of 20 than in those with a BMI of 30, flipping a common assumption.
Moderate-to-severe sleep apnea alone roughly doubled all-cause mortality risk. Adding comorbid insomnia to the same patients raised it further — evidence for treating the combination as its own risk category.
Rated against other symptom-management strategies women already use, masturbation scored among the highest for relieving mood changes and sleep disturbance. Nearly half said they'd try it if a doctor suggested it.
A survey of 243 people reporting persistent difficulty after a psychedelic trip found that how they responded in the moment, avoiding versus accepting, predicted whether trauma symptoms followed.
A secondary analysis of 8,376 adolescents built two models to predict who benefits from school-based mindfulness training. Both found a subgroup — and the difference in outcomes was trivial.
Both machine types cut breathing interruptions equally well in a 108-patient study. But auto-adjusting PAP's constantly shifting pressure came with more time awake and less total sleep on night one.
27 of 28 patients had no severe pain crises after treatment with reni-cel. But the sponsor ended the study early, and the reported analysis was not the one it was designed to test.
A Finnish national registry of over 11,000 women found up to 94% of endometriosis patients used menopausal hormone therapy after surgery, against 82% of a comparison group. The mix of hormones used is changing too.
Results posted to ClinicalTrials.gov show 15- and 25-day nirmatrelvir-ritonavir regimens produced no meaningful edge over placebo on cognitive, autonomic, or exercise-intolerance symptoms.
The barriers parents named most often were cost and the absence of any nearby service — not stigma, which the field has spent years treating as the main obstacle.
In 388 female athletes, a per cent fat Z-score below −1.0 more than doubled sensitivity for amenorrhoea against standard BMI thresholds. It gave up specificity to do it.
The same drug sold as Zepbound and Mounjaro reduced cocaine-evoked dopamine release and blocked drug-associated place preference in rodents. It's animal data, not a human addiction treatment.
In 3,873 middle-aged adults followed with repeated testing, waist-based categories of overweight and obesity showed larger effect sizes than BMI-based ones. The link to actual decline appeared only in men.
The estimate covers only populations in humanitarian need across Burkina Faso, Central African Republic, Chad, Mali, Niger and Nigeria — and it assumes nothing replaces the lost money.
The elevated risk showed up even in babies with no detectable malformation — which is not what the standard recessive-disease explanation predicts.
Fifty-five per cent of surveyed cricketers over 70 reported a basal cell carcinoma. A 29% response rate and self-reported diagnoses mean the number cannot be read as a rate — which is the finding.
Reanalyzed EEG data from a phase 3 trial finds lemborexant and zolpidem leave distinct signatures on sleep architecture. Only the slow-oscillation increase predicted less insomnia severity.
747 postmenopausal women were tested; 182 were scanned. Gray matter volume partially mediated the link between menopause age and cognition — in a cross-sectional design that cannot establish direction.
Women whose habits aligned with a favorable estrogen-metabolism pathway had up to 61% lower endometrial cancer risk. The score explains only a tenth of the variation it predicts.
Researchers deliberately withdrew CPAP for three nights to simulate untreated sleep apnea, then tested propranolol against placebo. It slowed the heart-rate surges tied to apnea events, at the price of lighter sleep.
A survey-based analysis of the European Health Interview Survey puts a price on Europe's obesity-related hospital use, and finds the strongest single association is not with obesity at all.
The first large instrumented-mouthguard dataset from elite Australian football finds women absorb greater rotational acceleration per impact, and that men's ruckmen sit in a category of their own.
In 2,077 children, higher processed-food intake at age 3 tracked with worse behavioral and emotional scores at age 5. It's an association from a birth cohort, not a trial, and can't establish that the food caused it.
A Taiwanese cohort of 26,000 women aged 20 to 50 puts numbers on a known tamoxifen risk in a population — younger, premenopausal — where data has been thinner.
The STABLED trial randomized 331 atrial fibrillation patients with a recent stroke to ablation plus anticoagulation or anticoagulation alone. The two groups ended up nearly identical.
Pooling 94 cohort studies, grip strength tracked with later dementia, depression and disability. The authors rate their own confidence in the numbers as limited to moderate.
Compared with a diabetes drug from another class, GLP-1 agonists were followed by fewer new diagnoses of alcohol, opioid, nicotine and other substance use disorders.
Sequencing 6,141 people turned high consanguinity into a research advantage: it produced natural human knockouts that population studies elsewhere almost never see.
Researchers profiled nearly 356,000 nuclei from post-mortem hippocampi across five groups. Chromatin accessibility in neurogenic cells was already altered in people with preclinical Alzheimer's pathology.
An 876-participant double-blind trial across 24 Chinese fertility centres nearly doubled serum 25-OHD in women with PCOS. Live births were 52.0% against 50.2% on placebo.
In 2,286 patients with sleep apnea undergoing major surgery, a measure of how deeply and how long oxygen fell — not the apnea-hypopnea index — tracked 30-day cardiovascular events and death.
SCREESCO randomised Swedish 60-year-olds to colonoscopy, stool testing, or nothing. After a median 4.8 years, overall cancer incidence barely moved; the stage distribution did.
A nationwide register study found a hazard ratio of 0.96 for all-cause death among users of menopausal hormone therapy. The raw death rate in users was higher — which is the part worth understanding.
A pooled analysis of five trials in treatment-resistant depression found sex differences in response. The largest ones appeared in both arms, which points at something other than the drug.
A four-arm randomised trial in 112 young women tested whether high-intensity circuit training and sleep-health counselling add up. On objective measures they did — by minutes.
A cluster-randomised trial across 15 population clusters found mosquito abundance collapsed in intervention areas and protective efficacy of 71–72% against symptomatic dengue.
The clearance story about sleep has been brain-centric. A Nature paper reports that in Drosophila, immune cells from the circulation do part of the job — and that blocking them shortens sleep.
A study in patients with VITT maps the trigger to a specific epitope on an adenoviral core protein, and to a single amino acid change that redirects the antibody onto a human platelet protein.
A 444,000-patient records study found a two-thirds lower rate of endometrial cancer when GLP-1 receptor agonists were added to progestin therapy. The two groups differed by eight years in average age.
A Swedish birth cohort of 2.76 million people found the cumulative male-to-female ratio for autism incidence had fallen to 1.2 by age 20 — and projects parity by 2024.
Nine children received a single infusion of AAV9 carrying the beta-galactosidase gene. Enzyme activity rose and substrate fell in every participant; some developmental measures held steady and others declined.
A Lancet study across 547,000 adults and 925 infectious diseases finds obesity raises the risk of severe infection across almost every pathogen type. The global estimate rests on modelling, not on the cohorts themselves.
A 1,151-person Hong Kong trial used trained lay counsellors, not clinicians, and no internet. The effect sizes are small, and the authors are explicit that they do not know whether it travels.
Seven seasons of records on 569 students found 9.0 injuries per 1,000 exposure days in the upper school. Most injuries came on gradually, and a quarter were recurrences.
The LIDA trial tested whether romosozumab's bone-building window closes early enough to shorten treatment. It met non-inferiority on hip bone density — at a single centre, with 50 participants, over one year.
Trained on 2,202 retracted paper mill articles, a text classifier flagged 9.87 percent of the cancer literature — including in the highest-impact journals. Flagged is not the same as fraudulent.
AlphaGenome takes a million base pairs of DNA and predicts what the sequence does. In Nature on January 28, it matched or beat the best existing models in 25 of 26 variant-effect evaluations.
In a 618-person randomized trial, 27.8% of the intervention group met the sustained-remission endpoint at 24 months against 21.2% of comparators. The confidence interval nearly touches no effect.
An Israeli case-control study found an apparent fourfold risk that vanished once the year before diagnosis was excluded. A Nordic study of 17,232 cancers found no association at all.
In the RECOVER extension, about a fifth of participants were in remission at 24 months and some who had not responded at 12 months did later. The second year had no control group.
In 85 people with mild cognitive impairment, transient beta-band events recorded at rest differed years before diagnosis. The sample is small and the finding has not been replicated.
Black cohosh, Chinese herbal medicine and vitamin D reached moderate certainty for specific outcomes. Most of the rest of the field — 158 studies deep — sits at low or very low certainty.
In a Pennsylvania cohort followed 7.5 years, the combination carried the highest risk when insomnia came with objectively short sleep. Insomnia with normal sleep duration showed no significant association.
An analysis of 104 trials found a 10 to 20 percent reduction under some diagnostic criteria and none under UK criteria. A separate review found a GDM diagnosis is not associated with more stillbirths.
FDA approved copper histidinate on the strength of two single-arm trials compared with an external control group. Children treated within four weeks of birth had a 78 percent lower risk of death.
An Oxford meta-analysis of 37 studies puts average regain at 0.4 kg a month across all weight-management drugs, and 0.8 kg a month for semaglutide and tirzepatide. Almost none of the newer-drug data runs past a year.
Among 16-to-24-year-olds in NHANES, those who slept longer on weekends had 41% lower odds of daily depressive symptoms. The survey measured both at the same moment, which limits what can be concluded.
Standard questionnaires found no daytime difference between suvorexant and placebo. Four-times-daily smartphone prompts found fatigue worse in the morning and better later. The trial had 40 people.
The NEJM paper reports 47 children in an open-label trial with no randomised control. The biomarker effect is large; the clinical claim rests on softer ground.
Matched against a comparator diabetes drug, incretin agonists were associated with an 8% lower rate of CPAP procedures — alongside a 32% lower mortality that should make readers cautious.
The biomarker effect reported at CTAD is large and sustained over two years. The sample is seven, the design is open dose-escalation, and imaging was available for three.
A ten-season analysis of 3,750 matches quantifies the load argument footballers have been making. It also states plainly what it cannot show: anything about injury.
A UK Biobank analysis of 96,365 people found a dose-response relationship between lifetime night-shift exposure and cardiovascular-kidney-metabolic disease — amplified in those who also slept short.
A study of 1.8 million Medicare beneficiaries found vaginal estrogen prescriptions went unfilled by the overwhelming majority — and were least likely of all in women with recurrent urinary tract infections.
WISDOM randomised 28,372 women to annual mammography or a risk-tailored schedule. The risk-based arm met its non-inferiority mark for advanced cancers — with caveats about who enrolled.
A population study covering all 15 million residents of Ontario found the rate of new ADHD medication prescriptions accelerated sharply after 2019 — and shifted decisively toward adults.
A small longitudinal study found reduced spindle activity over the temporal lobes in early Alzheimer's — and that lower temporal spindle density tracked with faster decline over up to seven years.
Semaglutide moved Alzheimer's biomarkers without moving the clinic. A separate liraglutide trial missed its primary endpoint on brain metabolism. Together they close a decade-old hypothesis — or at least narrow it.
A national registry analysis found the highest burden among 20-to-29-year-olds and a notable rise among girls aged 10 to 19, with rates concentrated in the Sierra region.
In a US cohort followed eight years, average weekday sleep rose from 8.1 to 8.3 hours while reports of fatigue and trouble sleeping increased. The socioeconomic gap in duration closed; the gap in symptoms did not.
An industry-standard indirect comparison of fezolinetant and elinzanetant found comparable reductions in vasomotor symptoms. Elinzanetant improved sleep disturbance more, without a difference in overall quality of life.
Nearly a million conscripts followed for three decades: obesity carried a 3.1-fold hazard for sepsis, and high cardiorespiratory fitness was associated with a 42% lower risk of dying from bacterial infection.
In a US cohort wearing wrist actigraphs, self-reported sleep exceeded measured sleep by about half an hour, with the gap largest on weekends and among Black adolescents and those from lower-income households.
Shared cell time raises transmission odds sharply — six months of it doubles them. But cell-level exposure explains only part of the genomic clustering, which undercuts contact tracing as a strategy.
In ATTAIN-2, the highest dose of the oral GLP-1 pill cut body weight 9.6% over 72 weeks in adults with type 2 diabetes, against 11.2% in the earlier trial of adults without diabetes.
In 59 facilities across Malawi and Uganda where 431,394 women gave birth, the APT-Sepsis programme reduced infection-related death, near-miss events and severe illness from 1.9% to 1.4%.
A Buenos Aires surveillance cohort estimates 80.8% effectiveness against RSV hospitalisation in infants under three months — close to what the licensing trial found, in a real programme.
Three papers published on 18 November argue the harm is not one ingredient but the replacement of whole-food diets. The evidence they assemble is strongest for diet quality and weakest where causation is hardest.
In 132 Minnesota school athletes, each step up a housing-based measure of socioeconomic status predicted about 24% fewer days to return-to-play clearance. Childhood adversity did not lengthen recovery.
An 18,476-person phase 3 trial and a small human challenge study landed the same day. Both favour the mRNA vaccine against influenza A; neither settles what it does against influenza B.
A meta-regression across 28 countries put pooled prevalence near 4-5% and standardised mortality ratios between 1.8 and 4.7, in a condition the Global Burden of Disease study does not count.
Age, sex, employment and socioeconomic level together explained under 1% of variance in insomnia severity. Perceived stress and generalised anxiety explained close to a third.
A decade-on review of chronic traumatic encephalopathy research reports that 5 of 70 veteran donors had features of the pathology and none met the full definition. A small UK rugby study looks elsewhere.
VESALIUS-CV randomised 12,257 patients with atherosclerosis or diabetes but no prior MI or stroke. Evolocumab reduced the three-point event rate from 8.0% to 6.2% over a median 4.6 years.
CORE and CORE2 enrolled 1,061 patients with severe hypertriglyceridaemia. The pancreatitis rate ratio was 0.15, but the higher dose came with liver enzyme rises and low platelets.
The first phase 1 results for CTX310 show gene editing can switch off a lipid gene in the liver. The trial was designed to look for harm, not benefit, and one participant died suddenly.
PISCES randomised 1,228 haemodialysis patients in Canada and Australia. The headline hazard ratio of 0.57 counts every event, not just the first — and that choice explains part of the gap.
A within-individual analysis of 505,474 people in Finland and Sweden found lower psychiatric hospitalisation on clozapine in every disorder studied except borderline personality disorder, with no excess mortality signal.
Sequencing hundreds of single neurons from 15 donors with CTE and 4 with repetitive head impacts but no CTE, researchers found the genomic damage tracked the disease, not the exposure.
Among 1,000 adults in Mwanza, overnight oximetry found sleep apnea in 17% of people with HIV and 19% without. Excessive daytime sleepiness, oddly, was more common in those without HIV.
The external validation of a micro-RNA signature outperformed imaging in 971 symptomatic patients. How it would perform in a lower-prevalence population is the question the study does not answer.
SURPASS-CN-INS randomised 257 adults at 26 Chinese hospitals. The 10 mg and 15 mg doses performed almost identically against placebo, and diarrhoea affected roughly a third of those on the higher doses.
The 162 mg group had 14.1% preterm or severe preeclampsia against 17.1% on 81 mg — a difference the trial could not distinguish from chance. Eight placental abruptions occurred on the higher dose and none on the lower.
An Australian laboratory trial played 20-second noise bursts to 68 sleeping adults. Arousal probabilities were low for both, and lower for wind farm noise at 40 and 50 decibels.
A small prospective cohort followed 62 reconstructions for a quarter century. The graft type made no difference, and the uninjured comparison group dropped out of sport faster.
A national insurance-claims analysis found long-term adherence far below what trial populations suggest, despite universal coverage and strict usage monitoring. The monitoring may be part of the problem.
The Nature paper pairs mouse mechanism with retrospective human cohorts: vaccination within 100 days of starting a checkpoint inhibitor was associated with better survival. Retrospective is the load-bearing word.
VENUSCANCER assembled individual records for 275,792 women from 103 cancer registries in 39 countries. The gaps it found are in what treatment women actually received, not only in whether they were diagnosed.
Fourteen studies covering 265 elite athletes used six different methods to identify relative energy deficiency. The spread in the answers is mostly a spread in the definitions.
Carriers of loss-of-function MC4R mutations had lower LDL and triglycerides than UK Biobank controls of similar adiposity, and lower cardiovascular risk. The brain sets body weight and lipids separately.
Seventy-two runners were sampled before and after the 2024 Boston Marathon. Every marker of kidney and intestinal injury rose, and staying hydrated did not change that.
Age-standardised incidence was 42.3 per 100,000 in Ghana and 43.1 in US non-Hispanic Black women, against 24.0 in white women. ER-positive rates diverged sharply in the other direction.
Pooling 31 studies of 556 patients, cortical 5-HT2A binding was lower in unmedicated depression than in controls. The post-mortem studies mostly found nothing, and the tracers used shape the result.
A Brazilian randomised trial found laser and radiofrequency equally effective for genitourinary syndrome of menopause. The one trial that used sham treatment found no benefit at all.
In 24,223 Swedish workers followed to 2018, insomnia and long sleep raised cardiovascular risk only when accompanied by daytime impairment — and rising sleep duration preceded disease.
A 13-year-old observational hypothesis finally got its randomised test. In ALASCCA, 160 mg of daily aspirin cut three-year recurrence from 14.1% to 7.7% in biomarker-selected patients.
Fourteen Swedish primary care patients were interviewed alongside a trial of nurse-led group sleep restriction therapy. Depression and life circumstances were what got in the way.
BCG and oral polio vaccine given within 48 hours to 5,420 babies under 2,000 g reduced deaths from infections other than tuberculosis. The effect is off-target, and the mechanism is unresolved.
Loneliness tracked with depression, perceived stress, psychotic-like experiences and suicidal ideation. A prevalence that high raises a question about what the measure is capturing.
In a 400-pair trial in Uganda where every family already had a bed net, insecticide-treated wraps reduced clinical malaria in infants from 2.14 to 0.73 cases per 100 person-weeks.
Over 17.4 years, high ultra-processed food intake was linked to a 24% higher colorectal cancer risk overall — and a 58% higher risk for right-sided colon cancer specifically.
Across 20,121 adults and 25 years of registry data, morningness markers predicted lower educational attainment but also lower odds of the bottom income quintile. Effects were absent in women.
A pooled analysis of 72,776 Korean adults found an 11% higher type 2 diabetes risk in the top intake quartile. An updated meta-analysis of 17 cohorts put the dose-response at 10% per 10% of intake.
Three BJSM reviews underpinning the FAIR consensus pooled 1.5 million participants and 108 concussion studies. Women and girls were 2.4% of the lower-limb evidence base.
In 99 patients with normal-pressure hydrocephalus, an open shunt valve improved gait velocity and balance versus a valve set so high it did nothing. Cognition and bladder control did not improve.
Across 2.48 million survey responses in 159 countries, the share of people with no one to turn to rose 13.4% between 2009 and 2024 — all of it after 2019.
In 99 men hospitalised for stress-related disorders, roughly four in five met probable criteria for trauma-associated sleep disorder — a condition that is not yet a recognised diagnosis.
Two phase 3b trials tested semaglutide 7.2 mg against the approved 2.4 mg dose. The extra weight loss was real but modest, and gastrointestinal side-effects and dysaesthesia rose alongside it.
ALEG's position holds that testosterone in postmenopausal women should be limited to hypoactive sexual desire disorder, and that pellets and compounded formulations are not recommended.
Ten weeks of a legal broad-spectrum CBD product produced detectable cannabigerol and cannabidivarin in most participants. After a 90-minute ride, detection rates rose to 74% and 84%.
An Australian cohort of 3,044 children found no protective factor held across all ages and outcomes. School safety mattered at age 6-7; belonging mattered at 12-13.
A UK-wide survey found cognitive and psychological symptoms outranked the ones menopause care is organised around, with higher ratings among Asian and Black respondents.
A survey of all 211 FIFA member associations found screening near-universal in South America and rare in Oceania, with youth screening starting anywhere from age 6 to 17.
A French prospective cohort followed adults with rare genetic obesity treated with the MC4R agonist in routine care. Weight fell about 20% in the first year and hunger scores dropped 62%.
Seltorexant held its effect over two weeks while zolpidem's faded, in a 364-person study run in 2017-2019 and published only now. The delay is disclosed in the paper itself.
In 311 adults aged 55 to 95, remission rates were 40% and 51% in the two intervention arms at one year, against 16% for online patient education. Adding human support helped a little.
In 270 patients whose voices persisted despite antipsychotics, the therapy beat matched clinical contact on hallucination severity by 2.26 points — significant, with a Cohen's d of 0.27.
Applying prevalence figures to UN population data yields 852 million adults with insomnia. Only 31 of 237 countries had a usable national estimate of their own.
In 12 clusters, 6% of girls in the intervention group experienced a maternal or perinatal death against 13% in control. The trial was a pilot, and the authors present it as such.
A Nature paper maps the route cerebrospinal fluid takes to neck lymph nodes, finds the route degrades with age, and reports a mechanical device that reopened it in old mice.
The first large replication project in the field found effect sizes shrank substantially on repeat, and reports that many original authors declined to engage with the attempt.